We assessed patient-provider communication in HIV care; data were from the 2019 Positive Perspectives Survey of people living with HIV (PLHIV) from 25 countries (n = 2389). A significantly greater proportion of recently diagnosed individuals were interested in being involved when it comes to decisions about their HIV treatment compared with any other group (72.8% [399/548], 63.1% [576/913], and 62.6% [581/928], diagnosis year: 2017–2019, 2010–2016, and pre-2010 respectively) but reported less understanding of their treatment compared with those reporting the longest duration (66.8% [366/548], 68.6% [626/913], and 77.3% [717/928], respectively). One-third of PLHIV with salient treatment-related concerns were uncomfortable discussing with providers. Of participants who felt that their HIV medication limited their life but did not discuss their concerns with their provider (n = 203), top reasons for not discussing were: perception nothing could be done (49.3% [100/203]), provider never brought up the issue (37.9% [77/203]), and not wanting to appear difficult (30.5% [62/203]). To continue to identify and address unmet treatment needs among PLHIV, providers need to ensure that there is ongoing open dialogue.

我们评估了 HIV 护理中的医患沟通；数据来自 2019 年对来自 25 个国家的艾滋病毒感染者 (PLHIV) 的积极观点调查 (n = 2389)。与任何其他组相比，在决定有关其 HIV 治疗的决定时，最近被诊断出的个体中有更大比例的人有​​兴趣参与其中（72.8% [399/548]、63.1% [576/913] 和 62.6% [581/ 928]，诊断年份：分别为 2017-2019 年、2010-2016 年和 2010 年之前），但与报告持续时间最长的患者相比，他们对治疗的了解较少（66.8% [366/548]、68.6% [626/913]和 77.3% [717/928]）。三分之一有明显治疗相关问题的 PLHIV 不愿意与提供者讨论。在认为自己的 HIV 药物限制了他们的生活但没有与提供者讨论他们的担忧的参与者中（n = 203），不讨论的主要原因是：认为无能为力（49.3% [100/203]），提供者从不提出了这个问题 (37.9% [77/203])，并且不想显得困难 (30.5% [62/203])。为了继续识别和解决 PLHIV 中未满足的治疗需求，提供者需要确保进行持续的公开对话。